Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
52,406,487
-
Number of holders
-
115
-
Total 13F shares, excl. options
-
34,631,078
-
Shares change
-
+2,800,223
-
Total reported value, excl. options
-
$457,133,912
-
Value change
-
+$34,811,430
-
Put/Call ratio
-
153%
-
Number of buys
-
66
-
Number of sells
-
-37
-
Price
-
$13.20
Significant Holders of 2seventy bio, Inc. - Common Stock, par value $0.0001 per share (TSVT) as of Q2 2022
136 filings reported holding TSVT - 2seventy bio, Inc. - Common Stock, par value $0.0001 per share as of Q2 2022.
2seventy bio, Inc. - Common Stock, par value $0.0001 per share (TSVT) has 115 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34,631,078 shares
of 52,406,487 outstanding shares and own 66% of the company stock.
Largest 10 shareholders include EcoR1 Capital, LLC (3,495,943 shares), WELLINGTON MANAGEMENT GROUP LLP (2,905,367 shares), BlackRock Inc. (2,528,841 shares), STATE STREET CORP (2,491,623 shares), VANGUARD GROUP INC (2,330,083 shares), BAKER BROS. ADVISORS LP (2,062,744 shares), ARMISTICE CAPITAL, LLC (1,600,000 shares), Madison Avenue Partners, LP (1,511,300 shares), Bain Capital Life Sciences Investors, LLC (1,408,901 shares), and Newtyn Management, LLC (1,346,796 shares).
This table shows the top 115 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.